Overexpression of tetraspanins affects multiple myeloma cell survival and invasive potential

Tali Tohami1, Liat Drucker, Hava Shapiro

  • 1Oncogenetic Laboratory, Meir Medical Center, Kfar Saba 44281, Israel.

Insights

Overexpressing CD81/CD82 tetraspanins in multiple myeloma (MM) cells reduced survival and inhibited metastasis. These findings highlight tetraspanins as potential therapeutic targets for MM treatment.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Cellular interactions with the microenvironment are crucial in multiple myeloma (MM), impacting treatment efficacy.
  • Tetraspanins, including CD81 and CD82, are membrane proteins linked to metastasis suppression but are underexpressed in MM.

Purpose of the Study:

  • To investigate the functional consequences of overexpressing CD81 and CD82 tetraspanins in MM cell lines.
  • To determine the impact of CD81/CD82 overexpression on MM cell survival, proliferation, adhesion, motility, and invasion.

Main Methods:

  • MM cell lines (CAG and RPMI 8226) were transfected with pEGFP-N1/C1 fusion vectors encoding CD81/CD82.
  • Flow cytometry, immunocytochemistry, and activity assays were used to assess cell morphology, survival, death, caspase activity, cell cycle, proliferation, oxidative stress, adhesion, motility, and invasion.

Main Results:

  • Overexpression of CD81/CD82 via pEGFP-N1 vectors decreased MM cell survival independently of caspases, reduced proliferation (Ki67), and increased intracellular glutathione.
  • Transfection with pEGFP-C1 vectors for CD81/CD82 reduced MM cell adhesion to various substrates, decreased motility, and attenuated invasion potential, evidenced by reduced MMP-9 activity.

Conclusions:

  • CD81/CD82 tetraspanins play a significant role in regulating multiple myeloma cell survival.
  • Overexpression of CD81/CD82 negatively impacts MM cell adhesion, motility, and invasion, supporting their function as tumor metastasis suppressors.